Experts Tell FDA Vaccines ‘Harm More People Than They Save,’ But NIH Director Believes Boosters Will Be Approved in Coming Weeks

During the Sept. 17 meeting of the FDA advisory panel to recommend whether to approve a third dose of Pfizer’s COVID vaccine, physicians pointed to data they said confirm the risks of Pfizer’s COVID vaccine don’t outweigh the benefits.